Amplification of the MYC gene is observed in 60% of TNBC cases, which is higher than in other subtypes of breast cancer and indicates a poor prognosis.19 Its encoded protein, c-Myc, significantly promotes TNBC cells to proliferate, migrate, invade, and resist to drug. This evidence concerns the gene MYC and breast carcinoma.